Penny stocks refer to shares of companies that typically trade hands for less than $5. They are frequently associated with small, lesser-known companies.
Biotech penny stocks, in particular, have the potential to generate enormous returns because they have more room to grow. One such penny biotech stock that Wall Street is strongly bullish about is Alto Neuroscience (ANRO). It is a clinical-stage biotech company that creates personalized treatments for mental health conditions such as depression, PTSD, and schizophrenia. The company believes that “complex problems demand precise solutions,” which means that approved medications for certain disorders may not work in the same way for each patient.
